On November 7, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers ... Read More
Events
08
Nov2017
08
Nov2017
The ongoing debate about repealing existing public and private drug programs and replacing them with a one-size-fits-all national pharmacare program ... Read More
03
Nov2017
INESSS Releases List of Drug Products Currently Being Reviewed Under the Continuous Evaluation Process
/ INESSS, Quebec, What's New
On November 2, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) announced they have now published ... Read More
01
Nov2017
The Patented Medicine Prices Review Board (PMPRB), in accordance with sections 89 and 100 of the Patent Act, released its ... Read More
31
Oct2017
PDCI is excited to announce another great addition to the PDCI team: John-Paul Dowson, Director, Reimbursement Strategy
/ PDCI, What's New
It is with great pleasure to announce after several months of a successful strategic partnership with Roubaix Strategies Inc. (RSI), ... Read More
30
Oct2017
We are pleased to announce that effective October 30, 2017 Jennifer Haig has joined PDCI Market Access Inc. as Manager, ... Read More
18
Oct2017
The Régie de l’assurance maladie du Québec (RAMQ) released its October update of the List of Medications on October 18, ... Read More
17
Oct2017
INESSS Releases Additional Information on the Continuous Evaluation of Drug Products – Mandatory Notification
/ INESSS, Quebec, What's New
On October 12, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers ... Read More